Overall Technical outlook

Price Summary

On 2026-10-19, Bristol-Myers Squibb Company's stock opened at 59.4, spiked to 59.87, declined to 58.44, and closed -0.96% down at 58.83, with 11549700 shares traded.
For the 52-week period, the stock's highest price is 68.09, and the lowest price is 0.0.

Technicals

Support and Resistance: At 58.83, the price is supported by 57.27 and resisted by 59.46. This indicates that the price for Bristol-Myers Squibb Company might fluctuate between these levels, with 57.27 acting as a support and 59.46 limiting further upward movement.
BMY supportResistance 815d14
Support/Resistance for BMY
Aroon: The current state of the AROON is neutral, with no clear trend direction indicated. This lack of directional bias suggests that the market may be in a phase of consolidation or uncertainty.
BMY aroon 815d14
Aroon chart for Bristol-Myers Squibb Company
Bol. Bands: The BOLL BANDS is in a neutral stance, not pointing to a clear trend in either direction. This suggests that the market may be lacking strong momentum, making it difficult to predict the next move.
BMY bbands 815d14
Bolinger Bands chart for Bristol-Myers Squibb Company
Parabolic SAR: The PSAR maintains its bullish stance, setting a significant support level that could help sustain the market's upward movement. This strong support suggests that Bristol-Myers Squibb Company is likely to continue trending higher, providing investors with confidence in the ongoing bullish momentum.
BMY psar 815d14
Parabolic Stop and Reverse chart for Bristol-Myers Squibb Company
Stochastic: The STOCHASTIC is in a neutral stance, with no clear direction indicated for the market. This lack of clarity suggests that the market may be in a state of equilibrium for BMY, with no strong trend emerging.
BMY stoch 815d14
Stochastic chart for Bristol-Myers Squibb Company
Tripple Moving Agerage: The Tripple MOVING AVG is currently neutral, showing no clear bias toward a rising or falling trend. This lack of directional clarity suggests that the market may be in a holding pattern, awaiting further developments.
BMY trippleSMA 815d14
Tripple SMA chart for Bristol-Myers Squibb Company

When evaluating a company's technical data, such as stock price charts or volume, it is essential to first consider its fundamentals. These fundamentals include financial stability, growth potential, and competitive advantages. Additionally, understanding the broader industry in which the company operates offers context that helps to make sense of technical patterns. By examining both the company's internal strengths and external environment, one can make more accurate and meaningful conclusions about its stock performance.